Avenue Therapeutics, Inc. SEC filings ATXI
Avenue Therapeutics, Inc. has 423 filings in SEC EDGAR's recent list, going back to Dec 30, 2015. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Feb 23, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Dec 5, 2025 | Dec 30, 2025 |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| DEF 14A | Proxy statement | May 6, 2024 | Jun 22, 2024 |
| DEF 14C | Information statement | Mar 18, 2024 | Mar 18, 2024 |
| PRE 14C | Filing | Mar 8, 2024 | Mar 8, 2024 |
| DEF 14C | Information statement | Jan 29, 2024 | Jan 29, 2024 |
| PRE 14C | Filing | Jan 17, 2024 | Jan 17, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 22, 2023 |
| DEFA14A | Additional proxy material | Jan 17, 2023 | — |
| DEFA14A | Additional proxy material | Jan 4, 2023 | — |
| DEFA14A | Additional proxy material | Nov 18, 2022 | — |
| DEF 14A | Proxy statement | Nov 18, 2022 | Dec 28, 2022 |
| PRE 14A | Preliminary proxy statement | Nov 8, 2022 | Dec 28, 2022 |
| DEF 14C | Information statement | Aug 22, 2022 | Aug 22, 2022 |
| PRE 14C | Filing | Aug 10, 2022 | Aug 10, 2022 |
| DEF 14A | Proxy statement | Nov 23, 2021 | Dec 16, 2021 |
| DEFA14A | Additional proxy material | May 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 16, 2020 |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 19, 2019 |
| DEFA14A | Additional proxy material | Jan 25, 2019 | — |
| DEFM14A | Definitive proxy statement | Dec 21, 2018 | — |
| PREM14A | Preliminary proxy statement | Dec 11, 2018 | Dec 11, 2018 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 13, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2018 | Jun 13, 2018 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ATXI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bay Harbor Islands, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1644963
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.